IP Verse

Wilk patent opposition analysis

The comprehensive analysis of Wilk opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Wilk

Stay updated with the latest patent oppositions filed by Wilk

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3694532
Neoantigen Identification Using HotspotsSEATTLE PROJECT CORP.Nov 26, 2025BIONTECH
EP4108671
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNATX, INC.Aug 20, 2025BIONTECH
EP3981437
Nucleic Acid VaccinesMODERNATX, INC.Jul 9, 2025BIONTECH
EP4023249
Nucleic Acid VaccinesMODERNATX, INC.Jul 9, 2025BIONTECH
EP3324979
Infectious Disease VaccinesMODERNAJul 10, 2023BIONTECH
EP2791160
Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA THERAPEUTICS, INC.Dec 2, 2022BIONTECH
EP3590949
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses ThereofMODERNATX, INC.Sep 23, 2022BIONTECH
EP3134131
Nucleic Acid VaccinesMODERNATX, INC.Sep 22, 2022BIONTECH
EP3682905
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNAAug 29, 2022BIONTECH
EP2976418
A Method For Producing A Product (E.G. Polypeptide) In A Continuous Cell Culture Fermentation Process.CMC BIOLOGICS A/SJun 30, 2021WILK

Top clients of Wilk

Top companies who are the clients of Wilk

CompanyTotal
BIONTECH11
BIONTECH CELL & GENE THERAPIES2
BIONTECH RNA PHARMACEUTICALS1
VICTREX MANUFACTURING1
WILK1